







The satellite race is intensifying as SpaceX/Space Exploration Technologies (SPXC) scales Starlink—reaching ~10.3M subscribers and ~$18.7B FY2025 revenue (+~33% YoY)—but posted a ~-$5B net loss and ~-$14B free cash flow in FY2025. AST SpaceMobile (ASTS) is set to support direct-to-device service with ~60 operator partnerships and nearly 3B potential subscribers, but remains loss-making (nearly -$342M net loss in FY2025) after issuing $1B convertible notes that could dilute shareholders. The article ultimately favors ASTS for a 2026 entry, citing earlier path to profitability (projected positive FCF in 2029) versus SpaceX’s continued heavy capital burn.
The real economic prize here is not “space internet” versus “space cellular”; it is control of the last-mile billing relationship. If direct-to-device works, the monetization layer likely accrues to carriers first, not the satellite operator, because they can bundle emergency coverage and rural service into higher-tier plans with almost no incremental capex. That makes T, VZ, TU, and VOD the cleaner 6-18 month beneficiaries than the pure-play satellite name, while AMT is only a second-order beneficiary if carriers use satellite to widen coverage without overbuilding towers.
The market is probably underpricing financing risk in ASTS and overpricing near-term product-market fit. Satellite deployment milestones can move the stock over days, but the hard catalyst is 1-3 quarters of disclosed carrier economics: if revenue-per-subscriber or wholesale pricing disappoints, another capital raise becomes the default path, which would pressure the equity even if technical progress continues. For SPCX, the issue is the opposite: it remains a structural winner but not an investable public equity, so any valuation debate mostly spills into sentiment around the broader satellite/launch complex rather than tradable cash flows.
Contrarian view: the consensus may be treating “more satellites” as synonymous with “more profits,” when the key variable is utilization and contract economics. If ASTS can show signed commercial terms that translate into meaningful EBITDA contribution by late 2026, the bear case weakens sharply; if not, the stock remains a funding story with equity dilution as the hidden overhang. The falsifier for the short-ASTS thesis is a clean 2-3 quarter runway of launch execution plus disclosed subscriber monetization that materially beats consensus; absent that, the downside remains a lower multiple and more dilution, not just higher volatility.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment